Aquestive Therapeutics: No AdCom For Anaphylm Derisks January Approval Catalyst

If you are interested in keeping up to date with stocks making moves within the biotech, pharma, and healthcare industries and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The share price of Aquestive Therapeutics, Inc. (NASDAQ: AQST ) was soaring yesterday, as the Warren, New Jersey-headquartered biotech, focused on "advancing medicines to bring meaningful improvement to patients' l ...